Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
In addition, CQD-KD1 precisely imaged tumor tissues in cancer-grafted mice by specifically targeting the over-expressed st14 on the tumor cell surface, which indicates CQD-KD1 as a potent probe for the fluorescence guided surgery of tumor resection.
|
31840729 |
2020 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Prss14/ST14 knockdown cells were used to test function in tumor growth and metastasis, peptides derived from the autocatalytic loop for activation were tested as preventive metastasis vaccine, and monoclonal and humanized antibodies to the same epitope were tested as new therapeutic candidates.
|
31426843 |
2019 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Overexpression of matriptase in tumor stroma is a poor prognostic indicator of extrahepatic bile duct cancer.
|
30729623 |
2019 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Upon reaching the tumor, the outer domain was cleaved by membrane type-serine protease 1 (MT-SP1) present in the tumor microenvironment, leading to enhanced localization of CTLA4 blockade.
|
30530991 |
2019 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
This ADC alone or in combination with cisplatin has the potential to improve the treatment outcomes of patients with TNBC as well as other tumors overexpressing activated matriptase.
|
29899836 |
2018 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
In the recurrent GBM tumor model, DNM3 and p65 showed increased expressions, whereas ST14 and p53 showed decreased expressions in tumor and blood exosomes of the recurrent GBM mouse model.
|
29449895 |
2017 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Matriptase is a serine protease associated with a wide variety of human tumors and carcinoma progression.
|
26942570 |
2017 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Mice with reduced levels of matriptase display a significant delay in oncogene-induced mammary tumour formation and blunted tumour growth.
|
25873032 |
2015 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Lastly, we found that the ability of TMPRSS2 to promote prostate cancer tumor growth and metastasis was associated with increased matriptase activation and enhanced degradation of extracellular matrix nidogen-1 and laminin β1 in tumor xenografts.
|
26018085 |
2015 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Curcumin treatment significantly resulted in reduced matrix metalloproteinase 9 activity and downregulation of cellular matriptase, a membrane-anchored serine protease with oncogenic roles in tumor formation and invasion.
|
23466486 |
2013 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
This study demonstrates that inflammation-associated colon carcinogenesis can be initiated and promoted solely by an intrinsic intestinal permeability barrier perturbation, establishes St14 as a critical tumor-suppressor gene in the mouse gastrointestinal tract and adds matriptase to the expanding list of pericellular proteases with tumor-suppressive functions.
|
22139080 |
2012 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Our data identify matriptase as an initiator of c-Met-Akt-mTor-dependent signaling axis in tumors and reveal mTor activation as an essential component of matriptase/c-Met-induced carcinogenesis.
|
21217780 |
2011 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Additionally, higher percentage tumor staining with matriptase was significantly correlated with the advanced N and M stages (P < 0.05).
|
17069593 |
2006 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
In addition, to validate gene expression data at the protein level, TADG-15 expression was evaluated by immunohistochemistry on paraffin embedded tissue from which all 11 primary tumor cell lines were established.
|
14584072 |
2003 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Analysis of clinicopathological parameters demonstrated a loss of matriptase associated with stage III/IV tumors as compared with stage I/II tumors (P = 0.030).
|
11948120 |
2002 |